Two of these patients (60-year-old female and 34-year-old male) presented with dyspnea on exertion (NYHA 2) and one patient with an elevated NT-proBNP (333 ng/l), corresponding to a HF prevalence of 2.6% in WD patients, all with a neurological manifestation. This evidence concerns the gene NPPB and hydrops fetalis.